电邮这篇文章 Surgical Treatment of Pulmonary Embolism Associated with COVID-19: First-Hand Experience
- 作者: Fedorov S.A.1, Zhurko S.A.1, Pichugin V.V.1,2, Chiginev V.A.1,2, Maximov A.L.1, Kulkarni S.V.2
-
隶属关系:
- Research Institute Specialized Cardiosurgical Clinical Hospital named after academician B. A. Korolev
- Privolzhsky Research Medical University
- 期: 卷 31, 编号 2 (2023)
- 页面: 283-292
- 栏目: Clinical reports
- URL: https://bakhtiniada.ru/pavlovj/article/view/252578
- DOI: https://doi.org/10.17816/PAVLOVJ109916
- ID: 252578
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
INTRODUCTION: Venous thromboembolic complications occupy one of the central positions in the structure of complications associated with CoronaVirus Disease 2019 (COVID-19). Characterized by high epidemiological threshold values, as well as an atypical clinical picture, they determine the need for new approaches to early diagnosis and active treatment. Surgical treatment of pulmonary embolism in itself is an extremely controversial method of reperfusion of the pulmonary arterial bed. Concerning pulmonary embolism associated with a new coronavirus infection, we did not find a single clinical case reported in the available literature. The article considers a clinical case of surgical treatment of pulmonary embolism against the background COVID-19 infection, demonstrates a comprehensive approach to treatment and describes peculiarities of the clinical picture.
CONCLUSION: Based on the presented case, one should note the importance of the anticoagulant therapy in a group of people with a virus-specific intervention to prevent recurrence of thromboembolic complications. Complex surgical treatment in combination with the proposed methods of anesthesiological support are the methods of choice in a group of people at intermediate-high and high risk of early cardiac death.
作者简介
Sergey Fedorov
Research Institute Specialized Cardiosurgical Clinical Hospital named after academician B. A. Korolev
编辑信件的主要联系方式.
Email: sergfedorov1991@yandex.ru
ORCID iD: 0000-0002-5930-3941
SPIN 代码: 3574-8749
MD, Cand. Sci. (Med.)
俄罗斯联邦, Nizhnу NovgorodSergey Zhurko
Research Institute Specialized Cardiosurgical Clinical Hospital named after academician B. A. Korolev
Email: zhurkoser@mail.ru
ORCID iD: 0000-0002-5222-1329
SPIN 代码: 9201-1438
MD, Cand. Sci. (Med.)
俄罗斯联邦, Nizhnу NovgorodVladimir Pichugin
Research Institute Specialized Cardiosurgical Clinical Hospital named after academician B. A. Korolev; Privolzhsky Research Medical University
Email: pichugin.vldmr@mail.ru
ORCID iD: 0000-0001-7724-0123
SPIN 代码: 6986-2331
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Nizhnу Novgorod; Nizhnу NovgorodVladimir Chiginev
Research Institute Specialized Cardiosurgical Clinical Hospital named after academician B. A. Korolev; Privolzhsky Research Medical University
Email: chiginevvladimir@yandex.ru
ORCID iD: 0000-0001-8977-1968
SPIN 代码: 2459-4291
MD, Dr. Sci. (Med.)
俄罗斯联邦, Nizhnу Novgorod; Nizhnу NovgorodAnton Maximov
Research Institute Specialized Cardiosurgical Clinical Hospital named after academician B. A. Korolev
Email: maximoval@mail.ru
ORCID iD: 0000-0002-7241-7070
SPIN 代码: 3748-4358
MD, Cand. Sci. (Med.)
俄罗斯联邦, Nizhnу NovgorodSanika Kulkarni
Privolzhsky Research Medical University
Email: ksanika59@yahoo.in
ORCID iD: 0000-0003-4910-3820
俄罗斯联邦, Nizhnу Novgorod
参考
- Claeys MJ, Vandekerckhove Y, Cosyns B, et al. Summary of 2019 ESC Guidelines on chronic coronary syndromes, acute pulmonary embolism, supraventricular tachycardia and dislipidaemias. Acta Cardiol. 2021;76(1):1–8. doi: 10.1080/00015385.2019.1699282
- Cао X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20(5):269–70. doi: 10.1038/s41577-020-0308-3
- Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–99. doi: 10.1111/jth.14817
- Llitjos J–F, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(7):1743–6. doi: 10.1111/jth.14869
- Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. J Am Coll Cardiol. 2020;75(23):2950–73. doi: 10.1016/j.jacc.2020.04.031
- Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2021;18(6):1421–4. doi: 10.1111/jth.14830
- Dolhnikoff M, Duarte–Neto AN, de Almeida Monteiro RA, et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost. 2020;18(6):1517–9. doi: 10.1111/JTH.14844
- Fogarty H, Townsend L, Cheallaigh CN, et al. COVID-19 coagulopathy in Caucasian patients. Br J Haematol. 2021;189(6):1044–9. doi: 10.1111/bjh.16749
- Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–74. doi: 10.1016/S0140-6736(20)30251-8
- Iba T, Levy J, Levi M, et al. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18(9):2103–9. doi: 10.1111/jth.14975
- Kloka FA, Kruipb MJHA, Van der Meerc NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–7. doi: 10.1016/j.thromres.2020.04.013
- Poissy J, Goutay J, Caplan M, et al. Pulmonary Embolism in COVID19 Patients: Awareness of an Increased Prevalence. Circulation. 2021;142(2):184–6. doi: 10.1161/CIRCULATIONAHA.120.047430
- Wichmann D, Sperhake J, Lütgehetmann M, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020;173(4):268–77. doi: 10.7326/M20-2003
- Medvedev AP, Fedorov SA, Trofimov NA, et al. Errors in diagnosis and treatment of pulmonary embolism. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2021;14(1):54 9. (In Russ). doi: 10.17116/kardio20211401154
补充文件
